logo
    Docs
 

Disease Report: Ulcerative colitis


Groups and Companies
Funding
Standard of Care
Unmet Medical Need
Novel Modalities and Combinations
Symptoms Evidence
Symptoms Targets
Pathogenesis Evidence
Pathogenesis Targets
Assays and Models

Here is a comprehensive answer to your query about patient groups, research groups, and companies developing drugs for Ulcerative Colitis (UC):

1. Patient groups:

  • Crohn's & Colitis Foundation (CCF): A leading nonprofit organization offering nationwide support groups (mostly virtual), educational resources, advocacy efforts, and funding for research to improve the lives of people with Crohn's disease and ulcerative colitis. They provide tailored support groups for various demographics including teens and young adults. https://www.crohnscolitisfoundation.org/
  • Crohn's & Colitis UK: The UK’s leading charity supporting people with Crohn's disease and ulcerative colitis, providing local networks, educational talks, social events, and advocacy. https://crohnsandcolitis.org.uk/
  • Connecting to Cure Crohn's and Colitis (CtoC): A nonprofit founded in 2011 to connect and support the IBD community, accelerate research, and raise awareness. https://www.connectingtocure.org/
  • Inflammatory Bowel Disease Support Group (IBDsupport.org): Provides support for patients with Crohn's disease and ulcerative colitis, including symptom management and community forums. https://www.ibdsupport.org/
  • Entyvio Connections Program: Patient ambassadors provide peer support for those living with moderate to severe UC or Crohn's disease. https://www.entyvio.com/community-of-support
  • Additional groups: Girls with Guts, The Great Bowel Movement, South Asian IBD Alliance (SAIA), Color of Gastrointestinal Illnesses (COGI) offer culturally or demographically focused support.
  • Advocacy and legislative efforts: CCF has successfully advocated for laws such as the Restroom Access Act (Ally's Law) in multiple states to improve patient rights.
    (Sources: Crohn's & Colitis Foundation, Crohn's & Colitis UK, Entyvio)

2. Academic groups and institutions:

3. Companies developing a drug:

4. Additional context:

  • The UC drug development pipeline is robust, with over 100 products in various stages of clinical development, including biologics, small molecules, and microbiome-based therapies.
  • Patient advocacy groups play a critical role in funding research, providing education, and advocating for patient rights and access to care.
  • Research institutions collaborate globally, often supported by nonprofit organizations like the Crohn's & Colitis Foundation, to accelerate discovery and clinical translation.
  • The market for UC treatments is expected to grow significantly, driven by increasing prevalence and advances in therapeutic options.

5. References:

  • Crohn's & Colitis Foundation: https://www.crohnscolitisfoundation.org/
  • McGill IBD Research Group: https://mcgillibd.ca/
  • UNSW Sydney IBD Research Group: https://www.unsw.edu.au/medicine-health/our-schools/clinical-medicine/research-impact/research-groups/infectious-disease-immunity-inflammation/inflammatory-bowel-disease-research-group
  • DelveInsight UC Drug Pipeline: https://www.delveinsight.com/blog/top-7-drugs-for-ulcerative-colitis-treatment
  • Mordor Intelligence UC Market: https://www.mordorintelligence.com/industry-reports/ulcerative-colitis-market/companies
  • Microbiotica: https://microbiotica.com/
  • Roivant-Pfizer collaboration: https://www.marketwatch.com/story/roivant-pfizer-form-company-to-develop-ulcerative-colitis-treatment-2022-12-01
  • STAT News on AltruBio: https://www.statnews.com/2024/05/21/altrubio-225-million-series-b-ulcerative-colitis-immune-checkpoint/
  • Janssen Pharmaceuticals: https://www.pharmaceutical-technology.com/comment/top-companies-ibd-space/
  • Mayo Clinic Clinical Trials: https://www.mayo.edu/research/clinical-trials/diseases-conditions/ulcerative-colitis
This overview provides a detailed picture of the key patient groups, research institutions, and companies involved in ulcerative colitis support, research, and drug development.